Brief: Kancera Decides On Directed New Issue And Rights Issue

Novakand Pharma AB

19/04/2021 07:35

April 19 (Reuters) - Kancera AB  KANC.ST :
    * DECIDES ON DIRECTED NEW ISSUE OF MAX OF SEK 20.4 MILLION
    * PLANS RIGHTS ISSUE OF UP TO SEK 101.2 MILLION
    * SUBSCRIPTION PRICE IN RIGHTS ISSUE IS SEK 12.70
    * SUBSCRIPTION PRICE IN DIRECTED SHARE ISSUE IS SEK 12.70
    * REASON FOR CAPITAL INCREASE IS TO FINANCE PLANNED
EXPANSION OF
CO'S BUSINESS

Source text for Eikon:  ID:nMFN2Vcyvk 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))